Patents by Inventor Ulrich J. Krull

Ulrich J. Krull has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7183050
    Abstract: Methods and devices for the detection and identification in a sample of one or more target molecules which bind to nucleic acid probe molecules are provided. The method includes contacting the sample with a surface that is coated with one or more gradients of nucleic acid or nucleic acid analog probe molecules that bind target molecules in the sample. Gradients are formed by varying a physical, structural or functional property of the probes on the surface; for example, the density of probe molecules bound to the surface. The coating layer or immobilization layer in which the gradient is formed is preferably continuous Determination of the location, speed and/or extent of hybridisation of a nucleic acid on a gradient surface is useful to identify target molecules bound to probes and/or to quantitatively measure the amount of the target in a sample.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: February 27, 2007
    Inventor: Ulrich J. Krull
  • Publication number: 20030157538
    Abstract: A biosensor for direct analysis of nucleic acid hybridization by use of an optical fiber functionalized with nucleic acid molecules and fluorescence transduction is disclosed. Nucleic acid probes are immobilized onto the surface of optical fibers and undergo hybridization with complementary nucleic acids introduced into the local environment of the sensor. Hybridization events are detected by the use of fluorescent compounds which bind into nucleic acid hybrids. The invention finds uses in detection and screening of genetic disorders, viruses, and pathogenic microorganisms. Biotechnology applications include monitoring of gene cultures and gene expression and the effectiveness (e.g. dose-response) of gene therapy pharmaceuticals. The invention includes biosensor systems in which fluorescent molecules are connected to the immobilized nucleic acid molecules. The preferred method for immobilization of nucleic acids is by in-situ solid phase nucleic acid synthesis.
    Type: Application
    Filed: January 7, 2003
    Publication date: August 21, 2003
    Inventors: Ulrich J. Krull, Paul A. Piunno, Robert H.E. Hudson, Masad Damha, Andre H. Uddin
  • Publication number: 20030055233
    Abstract: The invention provides improved methods and devices for the detection and identification in a sample of one or more target molecules which bind to probe molecules, particularly to nucleic acid probe molecules. The improved method is based on contacting the sample with a surface that is coated with one or more gradients of probe molecules, particlarly nucleic acid or nucleic acid analog probe molecules that serve to bind target molecules in the sample, particularly nucleic acids having sequences that are complementary or partially complementary to one or more probe molecules. A probe gradient generated on the surface is formed by the variation of a physical, structural or functional property of the probes on the surface. The gradient is generated, e.g.
    Type: Application
    Filed: April 18, 2002
    Publication date: March 20, 2003
    Inventor: Ulrich J. Krull
  • Patent number: 6503711
    Abstract: A biosensor for direct analysis of nucleic acid hybridazation by use of an optical fiber functionalized with nucleic acid molecules and fluorescence transduction is disclosed. Nucleic acid probes are immobilized onto the surface of optical fibers and undergo hybridization with complementary nucleic acids introduced into the local environment of the sensor. Hybridization events are detected by the use of fluorescent compounds which bind into nucleic acid hybrids. The invention finds uses in detection and screening of genetic disorders, viruses, and pathogenic micoorganisms. Biotechnology applications include monitoring of gene cultures and gene expression and the effectiveness (e.g. dose-response) of gene therapy pharmaceuticals. The invention includes biosensor systems in which fluorescent molecules are connected to the immobilized nucleic acid molecules. The preferred method for immobilization of nucleic acids is by in situ solid phase nucleic acid synthesis.
    Type: Grant
    Filed: February 16, 2000
    Date of Patent: January 7, 2003
    Inventors: Ulrich J. Krull, Paul A. Piunno, Robert H. E. Hudson, Masad Damha, Andre H. Uddin
  • Publication number: 20020137074
    Abstract: The invention provides methods for conducting hybridizations having increased selectivity of hybridization using substrates upon which probe nucleic acids are immobilized. The methods of this invention can be used to increase selectivity in nucleic acid diagnostic devices, such as biosensors and microarrays. The invention provides increased selectivity through control of the substrate surface chemistry and in particular, through control of the density of nucleic acids and other oligomers immobilized on a surface. The invention provides improved signal to noise in hybridization assays via enhanced differences in signal magnitude generated for fully matched target nucleic acid compared to partially matched target nucleic acid prior to signal processing.
    Type: Application
    Filed: November 21, 2001
    Publication date: September 26, 2002
    Inventors: Paul A.E. Piunno, James H. Watterson, Christopher C. Wust, Ulrich J. Krull
  • Patent number: 5449918
    Abstract: A novel optical chemical sensor for direct and continuous detection of organic species in process streams is described. The sensor is based on the use of surface plasmon resonance to amplify fluorescence emission from chemically selective membranes which can be deposited as Lang-muir-Blodgett films on thin metal island films.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: September 12, 1995
    Assignee: Her Majesty the Queen in Right of Canada, as represented by The Minister of National Defence of her Majesty's Canadian Government
    Inventors: Ulrich J. Krull, Reno F. DeBono
  • Patent number: 4849343
    Abstract: A lipid membrane is used as a chemo-receptive transducer for quantitative and semi-quantitative analysis of chemical test species in an electrolyte. The lipid membrane is contacted with an electrolyte containing the test species, and an electrical potential difference is applied across the membrane. From measurements of the trans-membrane ion current variation due to the presence of the test species, a quantitative analysis of the test species may be conducted, on a highly selective basis. Receptors showing a high degree of selectiveity towards the species are included in the membrane.
    Type: Grant
    Filed: March 18, 1987
    Date of Patent: July 18, 1989
    Inventors: Ulrich J. Krull, Michael Thompson
  • Patent number: 4824529
    Abstract: A protected, lipid membrane-based device useful as a chemoreceptive transducer is provided. The device includes a porous, membrane-protective layer attached to an underlying, lipid membrane. Also provided is a process for using the protected device to determine the concentration of a specified chemical species.There is additionally provided a lipid membrane-based gas sensor. The sensor includes a gas-permeable, hydrated upper layer attached to an underlying lipid membrane. Furthermore, the invention includes a process for using the gas sensor to determine the concentration of an inorganic ion formed from an inorganic ion-forming gas.
    Type: Grant
    Filed: November 27, 1987
    Date of Patent: April 25, 1989
    Assignee: Allied-Signal Inc.
    Inventors: Michael Thompson, Ulrich J. Krull, Krishna M. Kallury
  • Patent number: 4661235
    Abstract: A lipid membrane is used as a chemo-receptive transducer for quantitative and semi-quantitative analysis of chemical test species in an electrolyte. The lipid membrane is contacted with an electrolyte containing the test species, and an electrical potential difference is applied across the membrane. From measurements of the trans-membrane ion current variation due to the presence of the test species, a quantitative analysis of the test species may be conducted, on a highly selective basis. Receptors showing a high degree of selectivity towards the test species are included in the membrane.
    Type: Grant
    Filed: August 3, 1984
    Date of Patent: April 28, 1987
    Inventors: Ulrich J. Krull, Michael Thompson
  • Patent number: 4637861
    Abstract: A stabilized, lipid membrane-based device is provided. This device includes a plurality of membrane-forming lipids, and a support for stabilizing the lipid membrane. Each membrane-forming lipid includes a long chain through which the lipid is anchored to a binding site on the support, and another long chain unattached to the support. The support binding sites are spaced apart from one another to provide the lipid membrane with an appropriate molecular packing density.Also provided is a process for determining the concentration of a selected chemical species in an aqueous electrolytic solution, using an electrochemical cell formed from a lipid membrane-based device in accordance with the present invention. This process includes the step of applying across the lipid membrane of the device an electrical potential difference to produce an analytical signal based upon an increase in membrane ion permeability.
    Type: Grant
    Filed: December 16, 1985
    Date of Patent: January 20, 1987
    Assignee: Allied Corporation
    Inventors: Ulrich J. Krull, Michael Thompson